Medtronic CoreValve safer than surgery in bypass patients: study

(Reuters) - Medtronic's CoreValve non-invasive aortic valve replacement system led to significantly fewer deaths than open heart surgery after one year in patients who had previously undergone coronary bypass procedures, according to data from a clinical trial. One year after a diseased valve was replaced using the CoreValve transcatheter aortic valve replacement (TAVR) system, 11.4 percent of high-risk patients had died or suffered a major stroke versus 21.8 percent among those who had the valve replaced surgically. "The CoreValve System demonstrated important clinical advantages, including faster recovery compared to surgical valve replacement, offering heart teams an alternative to open heart surgery for this patient population," said Dr. John Conte, a professor of surgery at The Johns Hopkins Hospital, who presented the data at the Society of Thoracic Surgeons meeting in San Diego, in a statement.



via Health News Headlines - Yahoo News http://ift.tt/1Bpcdhk